Addictive potential of Tianeptine - the threatening reality - PubMed
Affiliations
- PMID: 19801742
Addictive potential of Tianeptine - the threatening reality
D Vadachkoria et al. Georgian Med News. 2009 Sep.
Abstract
A total of 24 patients (male volunteers), consumers of opiates in the past and suffering from Tianeptine abuse, were under clinical observation. The age range of patients was from 21 to 33 years. Tianeptine consumption history was 5 months duration on the average. The daily dose of preparation was 40 tablets (500 mg intravenous injections on the average). Patients used Tianeptine in combination with antihistamines (Promethazine, Suprastin). Research was carried out with the use of clinical, psychological and laboratory methods. Has been used Ch. Spilberger's scale of anxiety and T. Balashov's scale of depression. Comparison of withdrawal syndrome developed after cessation of Tianeptine and opiates consumption has shown that in case of Tianeptine, in the dynamic of withdrawal syndrome predominates well expressed high-level of anxiety and depression, while at opiates consumption - withdrawal syndrome is characterized by algesic events and vegetodysfunctions. Supposedly, Tianeptine, in contrast to other anti-depressants, stimulates release of neurotransmitter dopamine in nucleus Accumbens, that probably determine addictive potential of this drug. High level of anxiety, excitability and vegetodysfunctions, presumably could be explained by activation of the NMDA (glutamate receptors) receptor system in Locus coeruleus, and in vegetative ganglion. In the present article potential threat that may develop at Tianeptine consumption, especially in former opiate consumers, without medical purposes has been emphasized.
Similar articles
-
[The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
Kornowski J. Kornowski J. Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):311-8. Psychiatr Pol. 2002. PMID: 12647454 Clinical Trial. Polish.
-
[Does addiction to antidepressants exist? About a case of one addiction to tianeptine].
Guillem E, Lépine JP. Guillem E, et al. Encephale. 2003 Sep-Oct;29(5):456-9. Encephale. 2003. PMID: 14615695 French.
-
Long-term administration of tianeptine in depressed patients after alcohol withdrawal.
Malka R, Lôo H, Ganry H, Souche A, Marey C, Kamoun A. Malka R, et al. Br J Psychiatry Suppl. 1992 Feb;(15):66-71. Br J Psychiatry Suppl. 1992. PMID: 1389025 Clinical Trial.
-
Springer J, Cubała WJ. Springer J, et al. J Psychoactive Drugs. 2018 Jul-Aug;50(3):275-280. doi: 10.1080/02791072.2018.1438687. Epub 2018 Mar 1. J Psychoactive Drugs. 2018. PMID: 29494783 Review.
-
Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials.
Defrance R, Marey C, Kamoun A. Defrance R, et al. Clin Neuropharmacol. 1988;11 Suppl 2:S74-82. Clin Neuropharmacol. 1988. PMID: 2902922 Review.
Cited by
-
Smaga I, Bystrowska B, Gawliński D, Pomierny B, Stankowicz P, Filip M. Smaga I, et al. Neurotox Res. 2014 Aug;26(2):190-206. doi: 10.1007/s12640-014-9465-0. Epub 2014 Mar 21. Neurotox Res. 2014. PMID: 24652522 Free PMC article.
-
From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative Review.
Wagner ML, Pergolizzi J Jr, LeQuang JAK, Breve F, Varrassi G. Wagner ML, et al. Cureus. 2023 Jun 20;15(6):e40688. doi: 10.7759/cureus.40688. eCollection 2023 Jun. Cureus. 2023. PMID: 37485121 Free PMC article. Review.
-
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.
Samuels BA, Nautiyal KM, Kruegel AC, Levinstein MR, Magalong VM, Gassaway MM, Grinnell SG, Han J, Ansonoff MA, Pintar JE, Javitch JA, Sames D, Hen R. Samuels BA, et al. Neuropsychopharmacology. 2017 Sep;42(10):2052-2063. doi: 10.1038/npp.2017.60. Epub 2017 Mar 17. Neuropsychopharmacology. 2017. PMID: 28303899 Free PMC article.
-
Abuse and misuse of antidepressants.
Evans EA, Sullivan MA. Evans EA, et al. Subst Abuse Rehabil. 2014 Aug 14;5:107-20. doi: 10.2147/SAR.S37917. eCollection 2014. Subst Abuse Rehabil. 2014. PMID: 25187753 Free PMC article. Review.
-
Smith KE, Rogers JM, Strickland JC, Epstein DH. Smith KE, et al. Am J Drug Alcohol Abuse. 2021 Jul 4;47(4):455-466. doi: 10.1080/00952990.2021.1904408. Epub 2021 Apr 28. Am J Drug Alcohol Abuse. 2021. PMID: 33909525 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous